Japanese Biotech Stock News

GIGABYTE recently announced a collaboration with Capcom to promote the upcoming Resident Evil Requiem game through a themed custom PC giveaway and bundled monitor-game offers, while Capcom’s board approved director changes and new management roles effective April 1, 2026. Together, the gaming hardware tie-in and leadership reshuffle highlight how Capcom is leaning on flagship IP while refining its internal business focus. We’ll now examine how the Resident Evil Requiem collaboration with...

Kyocera stock moves after recent performance Kyocera (TSE:6971) has attracted attention after a 1 day decline of 1.4%, following a 4.1% fall over the past week, even though the share price shows a 12.7% gain over the past 3 months. See our latest analysis for Kyocera. Short term momentum has cooled, with the 7 day and 30 day share price returns both negative. However, the 90 day gain of 12.7% and 1 year total shareholder return of 54.3% still indicate stronger performance over a longer...

Wondering whether SoftBank Group's current share price actually lines up with its underlying value? This article walks through the numbers so you can see how the market is pricing the story. The stock closed at ¥3,578 after an 8.9% decline over the last 7 days, a 24.0% drop over 30 days and a 22.5% fall year to date, while the 1 year return sits at 83.4% and the 3 year return is very large at about 3x. These swings have come as SoftBank Group continues to be closely watched as a major...

Earlier this month, Metaplanet Inc. approved the creation of a wholly owned subsidiary, Metaplanet Ventures K.K., committing about ¥4,000 million over two to three years to invest in Bitcoin financial infrastructure, incubate early-stage domestic projects, and fund Bitcoin-focused grants in Japan. This move effectively turns Metaplanet into a corporate backer of Japan’s regulated Bitcoin ecosystem, linking its Bitcoin income business directly to venture, incubator, and developer-support...

Takeda Pharmaceutical stock snapshot Takeda Pharmaceutical (TSE:4502) has drawn investor attention after a period of steady trading, with its share price around ¥5,673 and multi year total returns along with recent revenue and net income figures in focus. See our latest analysis for Takeda Pharmaceutical. At around ¥5,673 per share, Takeda Pharmaceutical has delivered a 90 day share price return of 27.54%, while its 1 year total shareholder return of 33.82% points to building momentum beyond...

In early March 2026, Arrcus announced a collaboration with Fujitsu and 1Finity to combine FUJITSU-MONAKA Arm-based CPUs, ArcOS software-defined networking, and high-speed optical interconnects into a secure, energy-efficient infrastructure for distributed AI workloads from edge inference to large-scale training. This partnership highlights Fujitsu’s push to align compute, networking, and optical transport for emerging Physical and enterprise AI use cases such as smart factories, robotics,...

Why Marubeni’s Branford Castle deal matters for shareholders Marubeni (TSE:8002) has drawn investor attention after committing capital to Branford Castle Partners’ new flagship fund and agreeing to work alongside the firm to source and support global investment opportunities. See our latest analysis for Marubeni. The Branford Castle agreement lands while Marubeni’s share price sits at ¥5,591, with a 1 day share price return of 4.02% and 7 day return of 3.86%. However, the 30 day share price...

OMRON (TSE:6645) has released its SF2030 2nd Stage medium term plan, outlining a broad shift toward data driven operations. The plan highlights increased focus on industrial automation, healthcare, and targeted growth in Europe. This roadmap sets out multi year priorities for redirecting investment and reshaping the company’s business mix. OMRON, trading at ¥4,532.0, enters this new phase after a mixed share price record, with a 13.4% return year to date and a 3.5% return over 1 year,...

Japan Steel Works recently moved to expand its production capacity to serve rising orders from the recovering global nuclear energy sector, reinforcing its role in supplying advanced components and industrial machinery. This capacity build-out highlights how Japan Steel Works is tying its engineering and manufacturing expertise more closely to long-cycle nuclear infrastructure projects worldwide. We will now examine how this nuclear-focused capacity expansion shapes Japan Steel Works’...

Furukawa Electric has announced extensive executive transfers, new duties, and board director candidates following its March 5 Board of Directors meeting, with many changes taking effect from April 1 and further transitions planned through June 26, 2026. The reshuffle concentrates leadership around key domains such as digital infrastructure components, automotive systems, and energy infrastructure, suggesting a sharpened focus on technology-driven and infrastructure-related businesses. Next,...

Why Fujikura’s latest fiber optics moves matter for shareholders Fujikura (TSE:5803) has been in focus after new agreements with US Conec, Corning and Sumitomo Electric Lightwave to extend the MMC VSFF platform using PRIZM TMT expanded beam optics for high density connectivity. See our latest analysis for Fujikura. The PRIZM TMT agreements come at a time when momentum in Fujikura’s shares has been strong, with a 30 day share price return of 15.0% and a year to date share price return of...

Toro Neurovascular previously announced that the U.S. FDA had granted 510(k) clearance for its Toro 88 Superbore Catheter, with Kaneka Medical America LLC leading the U.S. commercial launch following the device’s first successful clinical use by Dr. Satoshi Tateshima. This launch underscores Kaneka’s deeper involvement in the neurovascular device market, pairing Toro’s catheter technology with Kaneka’s established U.S. sales and clinical support network. We’ll now examine how Kaneka’s role...

On March 10, 2026, TIS Inc. (TSE:3626) announced a share repurchase program of up to 20,000,000 shares, or 8.76% of outstanding shares, for ¥50,000 million running through September 30, 2026, with any repurchased shares above 5% of issued shares to be cancelled. This buyback, framed as a way to enhance shareholder returns and capital efficiency, could meaningfully reshape TIS’s balance between growth investment and capital return. We will examine how TIS’s sizeable share repurchase plan,...

In March 2026, Frontier Lithium announced it had signed a non-binding Memorandum of Understanding with Panasonic Energy and Mitsubishi to explore lithium hydroxide procurement and broader collaboration around the PAK Lithium Project in Ontario, aimed at supplying North America’s electric vehicle battery supply chain from 2030. A key insight is that Mitsubishi’s existing joint venture role in the PAK Lithium Project now sits within a wider potential offtake and technical cooperation framework...

GS Yuasa (TSE:6674) has drawn fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with reported fundamentals such as revenue, earnings and its value score of 4. See our latest analysis for GS Yuasa. At a share price of ¥5,193, GS Yuasa’s recent 1 month share price return of 15.99% and year to date share price return of 36.66% point to building momentum. The 1 year total shareholder return of 114.20% highlights how price gains and...

In March 2026, Lasertec drew heightened attention after reports of stronger-than-expected order momentum for its semiconductor inspection and wafer metrology equipment, following a sharp sector-wide selloff tied to inflation concerns. This sequence of macro-driven weakness followed by renewed product-focused interest highlights how quickly sentiment can swing around Lasertec’s core inspection business. We’ll now examine how this stronger-than-expected order momentum for semiconductor...

If you are wondering whether Asahi Kasei is still good value after its recent run, you are not alone. The key question now is how the current share price lines up with the underlying business. The stock closed at ¥1,616.5, with returns of 13.8% year to date, 60.5% over 1 year, 94.7% over 3 years and 38.5% over 5 years, although it has seen a 5.6% decline over the last 7 days and a 6.9% decline over the last 30 days. Recent news coverage around Asahi Kasei has focused on its position in the...

Toyota Motor (TSE:7203) is ramping up investment in solid-state battery technology. The company is preparing for potential mass production within the next two years. This push positions Toyota for a possible shift in how electric vehicles are powered and designed. Toyota is best known for its hybrid leadership, and this solid-state battery move adds a new angle to its electric vehicle plans. As global automakers compete to improve driving range, charging times, and battery safety, a...

February sales update draws fresh attention to MonotaRO MonotaRO (TSE:3064) has attracted fresh attention after reporting preliminary non-consolidated February 2026 sales of ¥28,454 million, compared with ¥24,262 million in February 2025. This provides investors with a timely read on current business activity. See our latest analysis for MonotaRO. Despite the solid February sales update, MonotaRO’s recent share price performance has been weak. The 30 day share price return shows an 11.82%...

Kyowa Kirin (TSE:4151) has moved to discontinue all clinical trials of rocatinlimab after a planned safety review highlighted malignancy concerns linked to OX40 pathway modulation, including confirmed and suspected Kaposi’s sarcoma cases. See our latest analysis for Kyowa Kirin. At a share price of ¥2,339, Kyowa Kirin has seen a 1-day share price return of 1.56% and a 7-day gain of 3.89%, compared with a weaker 30-day share price return of a 10.11% decline and a year-to-date share price...

Honda Motor (TSE:7267) has drawn fresh attention after its Q4 2026 update, where it outlined plans to cancel three U.S. electric vehicles, book up to ¥2.5t in charges, and refocus on hybrids. See our latest analysis for Honda Motor. The update has been met with a sharp reset in expectations. The 1 day share price return of a 5.63% decline and 30 day share price return of an 18.12% decline contrast with a 3 year total shareholder return of 37.78%. This suggests long term holders have still...

Mitsubishi Heavy Industries group company Turboden America was previously selected by Tallgrass to supply three Waste Heat-to-Power ORC plants at gas compressor stations in Ohio and Indiana, each expected to deliver around 10 MW of clean electricity and qualify for Inflation Reduction Act Investment Tax Credit incentives. This contract expands Mitsubishi Heavy Industries’ waste-heat-to-power footprint in the U.S., adding to its clean, reliable baseload power portfolio while potentially...

Computer Engineering & Consulting (TSE:9692) has posted its FY 2026 results with fourth quarter revenue of ¥18.6b and basic EPS of ¥51.56, backed by net income of ¥1,609m. The company’s quarterly revenue moved from ¥14.99b in FY 2025 Q4 to ¥18.6b in FY 2026 Q4, while basic EPS in those periods went from ¥23.72 to ¥51.56. This highlights higher earnings that put more focus on how sustainably it can defend and build its margins. See our full analysis for Computer Engineering & Consulting. With...

ToellLtd (TSE:3361) has reported another detailed quarter, with Q3 2026 revenue of ¥7.6b and net income of ¥550m translating into basic EPS of ¥29.31. The company’s quarterly revenue has moved from ¥7.8b in Q4 2025 to ¥6.1b in Q1 2026, ¥5.5b in Q2 2026 and ¥7.6b in Q3. Over the same period, EPS shifted from ¥20.90 to ¥14.59, ¥11.98 and then ¥29.31, providing a clear view of how the earnings line has tracked the top line. With trailing twelve month EPS of ¥76.77, a 5.3% net margin and a 2.38%...